Sebicef S 1000mg/500mg Injection
Marketer
Shiron Pharmaceuticals
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Sebicef S 1000mg/500mg Injection
Cefixime/Sulbactam injection (1000mg/500mg), a dual-action antibiotic, combats diverse bacterial infections by hindering microbial proliferation. Administration must be strictly under medical guidance. Consistent adherence to the prescribed dosage is crucial; premature cessation can compromise efficacy. Common side effects may include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require prompt emergency care. Inform your physician of all current medications, including those for pre-existing conditions, prior to commencing treatment. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, proper nutrition, and hydration promote faster recovery. Your physician may order laboratory tests to monitor treatment response.
Uses of Sebicef S 1000mg/500mg Injection
Managing bacterial infections
Major Benefits of Sebicef S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Sebicef S 1000mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Sebicef S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Sebicef S 1000mg/500mg Injection works:
Sebicef S 1000mg/500mg Injection contains Cefoperazone, an antibiotic, and Sulbactam, a beta-lactamase inhibitor. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Sebicef S 1000mg/500mg Injection and alcohol can trigger adverse reactions including facial flushing, tachycardia, nausea, thirst, chest discomfort, and hypotension (a disulfiram-like effect).
PregnancySAFE IF PRESCRIBED
The injectable medication Sebicef S (1000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Sebicef S (1000mg/500mg) is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no appreciable risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Sebicef S 1000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Sebicef S 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Sebicef S 1000mg/500mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Sebicef S 1000mg/500mg Injection :
Omit a dose of Sebicef S 1000mg/500mg Injection? Seek medical advice immediately.
Facts to Know About Sebicef S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently